[Upcoming Webinar] Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes

It is estimated that globally 1 in 8 individuals (2019 WHO figures) are affected by mental health problems causing problems with all aspects of daily life. The personal, economic burden, and associated increased risk in mortality underscore the need for the development of new and improved treatment options.

Clinical trials for psychiatry, including major depressive disorder, bipolar disorder, schizophrenia, and generalized anxiety disorder are unique and require an innovative and patient-centric approach to identification, enrollment, and retention of suitable participants. This webinar will explore and discuss how to operationalize enrollment among a heterogenous group of participants, placebo response and its robust mitigation strategies to ensure a successful trial.
These critical aspects of psychiatry clinical trials must be considered for operational excellence.

In this webinar, Medpace neuroscience clinical trial experts will explore the steps that can be made towards improving psychiatry trials, including recognizing the complexity of the population in protocol and trial design, understanding the patient's journey to optimize patient recruitment and retention, increasing diversity and equality, minimizing bias and placebo response mitigation, patient and site education for consistency and accuracy, and rater training and oversight.

Register now for the webinar to join the discussion with Medpace on strategies for successfully conducting psychiatry clinical trials.

Making the Complex Seamless^® in Psychiatry Clinical Development

Developing effective treatments for psychiatric disorders such as depression, bipolar disorder, anxiety disorders, PTSD, and schizophrenia requires a clinical research organization (CRO) partner with the specialized expertise and relevant experience to effectively address the unique challenges involved.

Streamline and accelerate your clinical research in psychiatry with support from our experienced, cross-functional team of medical and regulatory experts, clinical trial management teams, central labs, and core imaging labs. As a full-service and therapeutically-focused CRO with a unique approach to clinical development, Medpace specializes in the design and conduct of the most complex and challenging global trials in neuroscience clinical research, including psychiatry.